The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Monocytes as Targets for Cancer Therapies
Abstract
The importance of monocytes in modulating the lymphocyte dependent tumor necrosis is a target for cancer therapeutics. Monocytes produce a plethora of chemokine receptors. Lymphocyte to monocyte ratio is one of the negative factors in cancer patients. It is being targeted for treatment of abnormal lymphocytopenia and monocytosis in untreatable metastatic cancer patients. The aim of the chapter is to throw light on the circadian and psychological factors that modulate the progression of cancer and identify novel targets for controlling transformation of preneoplasms to neoplasms, invasiveness, and metastasis.
Related Content
|
Kamal Smimih, Bilal El-Mansoury, Chaima Azzouhri, Youssef Ait Hamdan, Fatima Ez-zahraa Saad, Merzouki Mohamed.
© 2024.
19 pages.
|
|
Fatima Ez-Zahraa Saad, Kamal Smimih, Abdelali Bitar, Manal Khanouchi.
© 2024.
12 pages.
|
|
Samira Boulbaroud, Hanane Khalki, Fatima Zahra Azzaoui.
© 2024.
28 pages.
|
|
Bilal El-Mansoury, Kamal Smimih, Youssef Ait Hamdan, Ahmed Draoui, Samira Boulbaroud, Arumugam Radhakrishnan Jayakumar.
© 2024.
23 pages.
|
|
Kamal Smimih, Chaima Azzouhri, Fatima Ez-Zahraa Saad, Youssef Ait Hamdan, Jawad Laadraoui, Nadia Zouhairi, Mohamed Merzouki.
© 2024.
17 pages.
|
|
Himel Mondal, Shaikat Mondal.
© 2024.
20 pages.
|
|
Hafida El Ghachi, Asmaa Haj-khlifa, Mjid Oukhrib, Lahcen Tamegart, Youssef Ait Hamdan, Abdelali Ben Maloui, Najib Kissani, Halima Gamrani.
© 2024.
25 pages.
|
|
|